(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification Number) |
N/A | ||
(Address of principal executive offices) | (Zip Code) |
Title of Each Class | Trading Symbol(s) | Name of Each Exchange on Which Registered | ||
☒ | Accelerated filer | ☐ | |
Non-accelerated filer | ☐ | Smaller reporting company | |
Emerging growth company | |||
Page | |
Cautionary Note Regarding Forward-Looking Statements | |
PART I | |
Item 1. Business | |
Item 1A. Risk Factors | |
Item 1B. Unresolved Staff Comments | |
Item 1C. Cybersecurity | |
Item 2. Properties | |
Item 3. Legal Proceedings | |
Item 4. Mine Safety Disclosures | |
PART II | |
Item 5. Market for Registrant’s Common Equity, Related Shareholder Matters and Issuer Purchases of Equity Securities | |
Item 6. [Reserved] | |
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations | |
Item 7A. Quantitative and Qualitative Disclosures About Market Risk | |
Item 8. Financial Statements and Supplementary Data | |
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure | |
Item 9A. Controls and Procedures | |
Item 9B. Other Information | |
Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections | |
PART III | |
Item 10. Directors, Executive Officers and Corporate Governance | |
Item 11. Executive Compensation | |
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Shareholder Matters | |
Item 13. Certain Relationships and Related Transactions, and Director Independence | |
Item 14. Principal Accountant Fees and Services | |
PART IV | |
Item 15. Exhibits, Financial Statement Schedules | |
Item 16. Form 10-K Summary | |
Signatures |
Number of Facilities | ||||||
Segment | Owned | Leased | Total | |||
North America | 157 | 151 | 308 | |||
Europe, MEA and APAC | 246 | 51 | 297 | |||
LATAM | 54 | 9 | 63 | |||
Corporate and significant regional offices | 1 | 5 | 6 | |||
Total (1) | 458 | 216 | 674 | |||
Location of Mill | Containerboard | Paperboard | Kraft Paper | Pulp | Total | |||||
Mahrt, AL | 1,031 | 1,031 | ||||||||
Longview, WA | 624 | 351 | 975 | |||||||
Fernandina Beach, FL | 928 | 928 | ||||||||
West Point, VA | 922 | 922 | ||||||||
Stevenson, AL | 864 | 864 | ||||||||
Covington, VA | 793 | 793 | ||||||||
Hodge, LA | 790 | 790 | ||||||||
Solvay, NY | 770 | 770 | ||||||||
Florence, SC | 733 | 733 | ||||||||
Seminole, FL | 620 | 620 | ||||||||
Evadale, TX | 55 | 531 | 586 | |||||||
Dublin, GA | 279 | 305 | 584 | |||||||
Roanoke Rapids, NC | 322 | 196 | 518 | |||||||
Demopolis, AL | 374 | 100 | 474 | |||||||
La Tuque, Quebec | 341 | 127 | 468 | |||||||
Hopewell, VA | 466 | 466 | ||||||||
Monterrey, MX | 402 | 402 | ||||||||
Cerro Gordo, MX | 259 | 88 | 347 | |||||||
Guadalajara, MX | 160 | 110 | 270 | |||||||
San Pablo, MX | 243 | 243 | ||||||||
Cowpens, SC | 234 | 234 | ||||||||
Los Reyes, MX | 158 | 158 | ||||||||
Battle Creek, MI | 150 | 150 | ||||||||
Dallas, TX | 127 | 127 | ||||||||
Missisquoi, VT | 99 | 99 | ||||||||
Stroudsburg, PA | 72 | 72 | ||||||||
San Luis Potosi, MX | 71 | 71 | ||||||||
Total North America | 9,241 | 3,502 | 852 | 100 | 13,695 |
Location of Mill | Containerboard | Paperboard | Kraft Paper | Graphic Paper | Total | |||||
Piteå, SWE | 794 | 794 | ||||||||
Roermond, NETH | 717 | 717 | ||||||||
Parenco, NETH | 441 | 248 | 689 | |||||||
Facture, FRA | 634 | 634 | ||||||||
Zulpich, GER | 573 | 573 | ||||||||
Hoya, GER | 474 | 88 | 562 | |||||||
Verzuolo, ITA | 551 | 551 | ||||||||
Nettingsdorf, AUS | 507 | 507 | ||||||||
Wrexen, GER | 259 | 88 | 347 | |||||||
Herzberg, GER | 287 | 287 | ||||||||
Saillat, FRA | 281 | 281 | ||||||||
Mengibar, SPA | 265 | 265 | ||||||||
Townsend Hook, U.K. | 259 | 259 | ||||||||
Ania, ITA | 254 | 254 | ||||||||
SSK, U.K. | 220 | 220 | ||||||||
Nervion, SPA | 176 | 176 | ||||||||
Morai, IND | 165 | 165 | ||||||||
Belgrade, SER | 132 | 132 | ||||||||
Navarra, SPA | 94 | 94 | ||||||||
Morava, CZK | 83 | 83 | ||||||||
Rethel, FRA | 72 | 72 | ||||||||
Total Europe, MEA and APAC | 6,681 | 463 | 270 | 248 | 7,662 |
Location of Mill | Containerboard | Paperboard | Kraft Paper | Total | ||||
Tres Barras, BRA | 650 | 650 | ||||||
Cali, COL | 129 | 70 | 121 | 320 | ||||
Pirapetinga, BRA | 143 | 143 | ||||||
Barbosa, COL | 127 | 127 | ||||||
Bernal, ARG | 77 | 77 | ||||||
Barranquilla, COL | 77 | 77 | ||||||
Uberaba, BRA | 72 | 72 | ||||||
Coronel Suarez, ARG | 57 | 57 | ||||||
Bento, BRA | 55 | 55 | ||||||
Total LATAM | 1,387 | 70 | 121 | 1,578 |

Years ended December 31, | |||
2025 | 2024 | ||
Net sales | $31,179 | $21,109 | |
Cost of goods sold | (25,136) | (16,914) | |
Gross profit | 6,043 | 4,195 | |
Selling, general and administrative expenses | (3,819) | (2,737) | |
Impairment and restructuring costs | (385) | (56) | |
Transaction and integration-related expenses associated with the Combination | (120) | (395) | |
Operating profit | 1,719 | 1,007 | |
Interest expense, net | (729) | (398) | |
Pension and other postretirement non-service income (expense), net | 30 | (24) | |
Other expense, net | (61) | (25) | |
Income before income taxes | 959 | 560 | |
Income tax expense | (260) | (241) | |
Net income | 699 | 319 | |
Net income attributable to noncontrolling interests | — | — | |
Net income attributable to common shareholders | $699 | $319 | |
Years ended December 31, | |||
2025 | 2024 | ||
Net sales (aggregate):(1) | |||
North America | $18,577 | $10,092 | |
Europe, MEA and APAC | 10,893 | 9,577 | |
LATAM | 2,113 | 1,711 | |
Segment Adjusted EBITDA: | |||
North America | $2,998 | $1,610 | |
Europe, MEA and APAC | 1,618 | 1,529 | |
LATAM | 485 | 378 | |
Years ended December 31, | |||
($ in millions) | |||
2025 | 2024 | ||
Net cash provided by operating activities | $3,392 | $1,483 | |
Net cash used for investing activities | $(2,143) | $(2,114) | |
Net cash (used for) provided by financing activities | $(1,298) | $607 | |
Years ended December 31, | |||
2025 | 2024 | ||
Net income | $699 | $319 | |
Income tax expense | 260 | 241 | |
Depreciation, depletion and amortization | 2,550 | 1,464 | |
Impairment and restructuring costs | 385 | 56 | |
Transaction and integration-related expenses associated with the Combination | 120 | 395 | |
Amortization of fair value step up on inventory | — | 224 | |
Interest expense, net | 729 | 398 | |
Pension and other postretirement non-service (income) expense, net | (30) | 24 | |
Share-based compensation expense | 139 | 206 | |
Other expense, net | 61 | 25 | |
Other adjustments | 26 | 34 | |
Adjusted EBITDA | $4,939 | $3,386 | |
SUMMARIZED STATEMENT OF OPERATIONS | Year ended December 31, |
2025 | |
Net sales to unrelated parties | $1,445 |
Net sales to Non-Obligor Subsidiaries | 1,162 |
Gross profit | 878 |
Interest expense, net with unrelated parties | (634) |
Interest expense, net with Non-Obligor Subsidiaries | (345) |
Net income and net income attributable to the Obligor Group | 963 |
SUMMARIZED BALANCE SHEETS | December 31, | December 31, | |
2025 | 2024 | ||
ASSETS | |||
Current amounts due from Non-Obligor Subsidiaries | $4,571 | $4,925 | |
Other current assets | 1,207 | 1,049 | |
Total current assets | $5,778 | $5,974 | |
Non-current amounts due from Non-Obligor Subsidiaries | $3,355 | $2,848 | |
Other non-current assets | 918 | 370 | |
Total non-current assets | $4,273 | $3,218 | |
LIABILITIES | |||
Current amounts due to Non-Obligor Subsidiaries | $9,130 | $9,681 | |
Other current liabilities | 482 | 1,122 | |
Total current liabilities | $9,612 | $10,803 | |
Non-current amounts due to Non-Obligor Subsidiaries | $7,447 | $6,604 | |
Other non-current liabilities | 11,823 | 9,644 | |
Total non-current liabilities | $19,270 | $16,248 |
Defined Benefit Pension Plans | |||
50 Basis Point Increase | 50 Basis Point Decrease | ||
Discount rate | $8 | $(8) | |
Compensation level | 1 | (1) | |
Expected long-term rate of return on plan assets | (35) | 35 | |
Page | |
Report of Independent Registered Public Accounting Firm (Auditor Name PCAOB ID: | |
Consolidated Balance Sheets as of December 31, 2025 and December 31, 2024 | |
Consolidated Statements of Operations for the years ended December 31, 2025, December 31, 2024 and December 31, 2023 | |
Consolidated Statements of Comprehensive Income (Loss) for the years ended December 31, 2025, December 31, 2024 and December 31, 2023 | |
Consolidated Statements of Cash Flows for the years ended December 31, 2025, December 31, 2024 and December 31, 2023 | |
Consolidated Statements of Changes in Equity for the years ended December 31, 2025, December 31, 2024 and December 31, 2023 | |
Notes to Consolidated Financial Statements |
December 31, 2025 | December 31, 2024 | ||
Assets | |||
Current assets: | |||
Cash and cash equivalents (amounts related to consolidated variable interest entities of $ $ | $ | $ | |
Accounts receivable, net (amounts related to consolidated variable interest entities of $ $ | |||
Inventories | |||
Other current assets | |||
Total current assets | |||
Property, plant and equipment, net | |||
Goodwill | |||
Intangibles, net | |||
Prepaid pension asset | |||
Other non-current assets (amounts related to consolidated variable interest entities of $ $ | |||
Total assets | $ | $ | |
Liabilities and Equity | |||
Current liabilities: | |||
Accounts payable | $ | $ | |
Accrued expenses | |||
Accrued compensation and benefits | |||
Current portion of debt | |||
Other current liabilities | |||
Total current liabilities | |||
Non-current debt due after one year (amounts related to consolidated variable interest entities of $ | |||
Deferred tax liabilities | |||
Pension liabilities and other postretirement benefits, net of current portion | |||
Other non-current liabilities (amounts related to consolidated variable interest entities of $ and $ | |||
Total liabilities | |||
Commitments and Contingencies (Note 21) | |||
Equity: | |||
Preferred stock, $ | |||
Common stock, $ shares outstanding at December 31, 2025 and December 31, 2024, respectively | |||
Deferred shares, € December 31, 2025 and December 31, 2024, respectively | |||
Treasury stock, at cost; December 31, 2024, respectively | ( | ( | |
Capital in excess of par value | |||
Accumulated other comprehensive loss | ( | ( | |
Retained earnings | |||
Total shareholders’ equity | |||
Noncontrolling interests | |||
Total equity | |||
Total liabilities and equity | $ | $ |
Years ended December 31, | |||||
2025 | 2024 | 2023 | |||
Net sales | $ | $ | $ | ||
Cost of goods sold | ( | ( | ( | ||
Gross profit | |||||
Selling, general and administrative expenses | ( | ( | ( | ||
Impairment and restructuring costs | ( | ( | ( | ||
Transaction and integration-related expenses associated with the Combination | ( | ( | ( | ||
Operating profit | |||||
Interest expense, net | ( | ( | ( | ||
Pension and other postretirement non-service income (expense), net | ( | ( | |||
Other expense, net | ( | ( | ( | ||
Income before income taxes | |||||
Income tax expense | ( | ( | ( | ||
Net income | |||||
Net income attributable to noncontrolling interests | ( | ||||
Net income attributable to common shareholders | $ | $ | $ | ||
Basic earnings per share attributable to common shareholders | $ | $ | $ | ||
Diluted earnings per share attributable to common shareholders | $ | $ | $ | ||
The accompanying notes are an integral part of these Consolidated Financial Statements. | |||||
Years ended December 31, | |||||
2025 | 2024 | 2023 | |||
Net income | $ | $ | $ | ||
Other comprehensive income (loss), net of tax: | |||||
Foreign currency translation gain (loss) | ( | ||||
Defined benefit pension and other postretirement benefit plans | ( | ( | |||
Net (loss) gain on cash flow hedges | ( | ||||
Other comprehensive income (loss), net of tax | ( | ||||
Comprehensive income (loss) | ( | ||||
Comprehensive income attributable to noncontrolling interests | ( | ||||
Comprehensive income (loss) attributable to common shareholders | $ | $( | $ | ||
The accompanying notes are an integral part of these Consolidated Financial Statements. | |||||
Years ended December 31, | |||||
2025 | 2024 | 2023 | |||
Operating activities: | |||||
Net income | $ | $ | $ | ||
Adjustments to reconcile consolidated net income to net cash provided by operating activities: | |||||
Depreciation, depletion and amortization | |||||
Cash surrender value increase in excess of premiums paid | ( | ( | |||
Impairment charges | |||||
Share-based compensation expense | |||||
Deferred income tax benefit | ( | ( | ( | ||
Pension and other postretirement funding more than cost | ( | ( | ( | ||
Other | ( | ||||
Change in operating assets and liabilities, net of acquisitions and divestitures: | |||||
Accounts receivable | ( | ||||
Inventories | |||||
Other assets | ( | ( | |||
Accounts payable | ( | ( | ( | ||
Income taxes | ( | ( | ( | ||
Accrued liabilities and other | ( | ||||
Net cash provided by operating activities | |||||
Investing activities: | |||||
Capital expenditures | ( | ( | ( | ||
Cash paid for purchase of businesses, net of cash acquired | ( | ( | ( | ||
Proceeds from corporate owned life insurance | |||||
Proceeds from sale of property, plant and equipment | |||||
Other | |||||
Net cash used for investing activities | ( | ( | ( | ||
Financing activities: | |||||
Additions to debt | |||||
Repayments of debt | ( | ( | ( | ||
Debt issuance costs | ( | ( | |||
Changes in commercial paper, net | ( | ||||
Other debt (repayments) additions, net | ( | ( | |||
Repayments of finance lease liabilities | ( | ( | ( | ||
Tax paid in connection with shares withheld from employees | ( | ( | |||
Purchases of treasury stock | ( | ( | |||
Cash dividends paid to shareholders | ( | ( | ( | ||
Other | ( | ( | |||
Net cash (used for) provided by financing activities | ( | ( | |||
Effect of exchange rate changes on cash and cash equivalents | ( | ||||
Increase (decrease) in cash and cash equivalents | ( | ||||
Cash and cash equivalents at January 1 | |||||
Cash and cash equivalents at December 31 | $ | $ | $ | ||
Shares of Common Stock | Common Stock | Capital in Excess of Par Value | Treasury Stock | Retained Earnings | Accumulated Other Comprehensive Loss | Total Shareholders' Equity | Noncontrolling Interest (“NCI”) | Total | |
Balance at December 31, 2022(1) | $ | $ | $( | $ | $( | $ | $ | $ | |
Net income | — | — | — | — | — | ||||
Other comprehensive income, net of tax | — | — | — | — | — | — | |||
Share-based compensation | — | — | — | — | — | — | |||
Issuance of common stock | — | — | — | — | — | — | — | — | |
Purchases of treasury stock | — | — | — | ( | — | — | ( | — | ( |
Shares distributed by Smurfit Kappa Employee Trust | — | — | ( | — | — | — | |||
Dividends declared ($ | — | — | — | — | ( | — | ( | — | ( |
Balance at December 31, 2023 | ( | ( | |||||||
Net income | — | — | — | — | — | — | |||
Other comprehensive loss, net of tax | — | — | — | — | — | ( | ( | — | ( |
Share-based compensation | — | — | — | — | — | — | |||
Shares distributed by Smurfit Kappa Employee Trust | — | — | ( | — | — | — | |||
Purchases of treasury stock | — | — | — | ( | — | — | ( | — | ( |
Shares of Smurfit Westrock common stock issued to WestRock shareholders and NCI assumed as a result of the Merger | — | — | — | ||||||
Converted WestRock RSUs and Options attributable to pre- Combination services | — | — | — | — | — | — | |||
Issuance of common stock net of tax paid in connection with shares withheld from employees | — | — | ( | — | ( | — | ( | ||
Reclassification from retained earnings to accumulated other comprehensive loss | — | — | — | — | ( | — | |||
Dividends declared ($ | — | — | — | ( | — | ( | — | ( | |
Balance at December 31, 2024 | ( | ( | |||||||
Net income | — | — | — | — | — | — | |||
Other comprehensive income, net of tax | — | — | — | — | — | — | |||
Share-based compensation | — | — | — | — | — | — | |||
Shares distributed by Smurfit Kappa Employee Trust | — | — | ( | — | — | — | |||
Issuance of common stock net of tax paid in connection with shares withheld from employees | — | — | ( | — | ( | — | ( | ||
Cancellation of deferred shares by Smurfit Kappa Employee Trust | — | — | — | ( | — | — | |||
Dividends declared ($ | — | — | — | ( | — | ( | — | ( | |
Balance at December 31, 2025 | $ | $ | $( | $ | $( | $ | $ | $ |
2025 | 2024 | ||
Outstanding payment obligations at January 1 | $ | $ | |
Assumed as part of the Combination | |||
Amounts added during the period | |||
Amounts settled during the period | ( | ( | |
Outstanding payment obligations at December 31 | $ | $ |
Cash paid for outstanding WestRock Stock(1) | $ |
Smurfit Westrock Shares issued to WestRock Shareholders(2) | |
Converted WestRock Options and WestRock RSU Awards attributable to pre-Combination service(3) | |
Settlement of pre-existing relationships, trade and other payable and receivable balances with WestRock(4) | ( |
Aggregate Merger Consideration | $ |
Preliminary Allocation | Measurement Period Adjustments | Final Allocation | |||
Identifiable net assets: | |||||
Cash and cash equivalents | $ | $ | $ | ||
Accounts receivable | |||||
Inventories | |||||
Other current assets | ( | ||||
Property, plant and equipment | |||||
Intangibles | |||||
Prepaid pension asset | |||||
Other non-current assets | |||||
Accounts payable | ( | ( | |||
Accrued compensation and benefits | ( | ( | |||
Current portion of debt | ( | ( | |||
Other current liabilities | ( | ( | ( | ||
Non-current debt due after one year | ( | ( | ( | ||
Deferred tax liabilities | ( | ( | |||
Pension liabilities and other postretirement benefits, net of current portion | ( | ( | |||
Other non-current liabilities | ( | ( | ( | ||
Noncontrolling interests | ( | ( | |||
Identifiable net assets acquired as of July 5, 2024 | |||||
Goodwill arising on Merger | ( | ||||
Aggregate Merger Consideration | $ | $ | $ |
Fair Value | Weighted Average Useful Lives (in years) | ||
Customer relationships | $ | ||
Trade names and trademarks | |||
Developed technology | |||
Software assets | |||
Land use rights | |||
Intangible assets acquired | $ |
Years ended December 31, | |||
2024 | 2023 | ||
Net sales | $ | $ | |
Net income (loss) attributable to common shareholders | $ | $( | |
Years ended December 31, | |||||
2025 | 2024 | 2023 | |||
Net sales (unaffiliated customers) | |||||
Ireland (country of domicile) | $ | $ | $ | ||
U.S. | |||||
Mexico | |||||
Germany | |||||
France | |||||
Other Americas | |||||
Other Europe, MEA and APAC | |||||
Total | $ | $ | $ | ||
December 31, | |||
2025 | 2024 | ||
Long-lived assets(1) | |||
Ireland (country of domicile) | $ | $ | |
U.S. | |||
Other Americas | |||
Other Europe, MEA and APAC | |||
Total | $ | $ | |
Year ended December 31, 2025 | North America | Europe, MEA and APAC | LATAM | Total | |||
Net sales (unaffiliated customers) | $ | $ | $ | $ | |||
Add net sales (intersegment) | |||||||
Net sales (aggregate) | |||||||
Less segment expenses: | |||||||
Segment cost of goods sold | ( | ( | ( | ||||
Segment selling, general and administrative expenses | ( | ( | ( | ||||
( | ( | ( | ( | ||||
Segment Adjusted EBITDA | $ | $ | $ | $ | |||
Unallocated corporate costs | ( | ||||||
Depreciation, depletion and amortization | ( | ||||||
Impairment and restructuring costs | ( | ||||||
Transaction and integration-related expenses associated with the Combination | ( | ||||||
Interest expense, net | ( | ||||||
Pension and other postretirement non-service income, net | |||||||
Share-based compensation expense | ( | ||||||
Other expense, net | ( | ||||||
Other adjustments | ( | ||||||
Income before income taxes | $ |
Year ended December 31, 2024 | North America | Europe, MEA and APAC | LATAM | Total | |||
Net sales (unaffiliated customers) | $ | $ | $ | $ | |||
Add net sales (intersegment) | |||||||
Net sales (aggregate) | |||||||
Less segment expenses: | |||||||
Segment cost of goods sold | ( | ( | ( | ||||
Segment selling, general and administrative expenses | ( | ( | ( | ||||
( | ( | ( | ( | ||||
Segment Adjusted EBITDA | $ | $ | $ | $ | |||
Unallocated corporate costs | ( | ||||||
Depreciation, depletion and amortization | ( | ||||||
Impairment and restructuring costs | ( | ||||||
Transaction and integration-related expenses associated with the Combination | ( | ||||||
Amortization of fair value step up on inventory | ( | ||||||
Interest expense, net | ( | ||||||
Pension and other postretirement non-service expense, net | ( | ||||||
Share-based compensation expense | ( | ||||||
Other expense, net | ( | ||||||
Other adjustments | ( | ||||||
Income before income taxes | $ |
Year ended December 31, 2023 | North America | Europe, MEA and APAC | LATAM | Total | |||
Net sales (unaffiliated customers) | $ | $ | $ | $ | |||
Add net sales (intersegment) | |||||||
Net sales (aggregate) | |||||||
Less segment expenses: | |||||||
Segment cost of goods sold | ( | ( | ( | ||||
Segment selling, general and administrative expenses | ( | ( | ( | ||||
( | ( | ( | ( | ||||
Segment Adjusted EBITDA | $ | $ | $ | $ | |||
Unallocated corporate costs | ( | ||||||
Depreciation, depletion and amortization | ( | ||||||
Impairment and restructuring costs | ( | ||||||
Transaction and integration-related expenses associated with the Combination | ( | ||||||
Interest expense, net | ( | ||||||
Pension and other postretirement non-service expense, net | ( | ||||||
Share-based compensation expense | ( | ||||||
Other expense, net | ( | ||||||
Income before income taxes | $ |
Years ended December 31, | |||||
2025 | 2024 | 2023 | |||
Capital expenditures: | |||||
North America | $ | $ | $ | ||
Europe, MEA and APAC | |||||
LATAM | |||||
Total per reportable segments | |||||
Corporate | |||||
Total capital expenditures | $ | $ | $ | ||
December 31, | |||
2025 | 2024 | ||
Assets: | |||
North America | $ | $ | |
Europe, MEA and APAC | |||
LATAM | |||
Total reportable segments | |||
Corporate(1) | |||
Total assets | $ | $ | |
Year ended December 31, 2025 | |||||||
North America | Europe, MEA and APAC | LATAM | Total | ||||
Revenue by product: | |||||||
Paper | $ | $ | $ | $ | |||
Packaging | |||||||
Total | $ | $ | $ | $ | |||
Year ended December 31, 2024 | |||||||
North America | Europe, MEA and APAC | LATAM | Total | ||||
Revenue by product: | |||||||
Paper | $ | $ | $ | $ | |||
Packaging | |||||||
Total | $ | $ | $ | $ | |||
Year ended December 31, 2023 | |||||||
North America | Europe, MEA and APAC | LATAM | Total | ||||
Revenue by product: | |||||||
Paper | $ | $ | $ | $ | |||
Packaging | |||||||
Total | $ | $ | $ | $ | |||
Years ended December 31, | |||||
2025 | 2024 | 2023 | |||
Impairment charges | $ | $ | $ | ||
Restructuring costs | |||||
Impairment and restructuring costs | $ | $ | $ | ||
Years ended December 31, | |||||
2025 | 2024 | 2023 | |||
Impairment of property, plant and equipment | $ | $ | $ | ||
Impairment of other assets | |||||
Total impairment charges | $ | $ | $ | ||
Years ended December 31, | |||||
2025 | 2024 | 2023 | |||
North America | $ | $ | $ | ||
Europe, MEA and APAC | |||||
LATAM | |||||
Total impairment charges recognized for property, plant and equipment | $ | $ | $ | ||
Years ended December 31, | |||||
2025 | 2024 | 2023 | |||
North America | $ | $ | $ | ||
Europe, MEA and APAC | |||||
LATAM | |||||
Total restructuring costs | $ | $ | $ | ||
Years ended December 31, | |||||
2025 | 2024 | 2023 | |||
Severance charges | $ | $ | $ | ||
Other costs | |||||
Total restructuring costs | $ | $ | $ | ||
Severance charges | Other costs | Total | |||
Balance at December 31, 2024 | $ | $ | $ | ||
Charges for the period | |||||
Payments | ( | ( | ( | ||
Balance at December 31, 2025 | $ | $ | $ |
Years ended December 31, | |||||
2025 | 2024 | 2023 | |||
Transaction-related reversals (expenses) associated with the Combination | $ | $( | $( | ||
Integration-related (expenses) associated with the Combination | ( | ( | |||
Total transaction and integration-related expenses associated with the Combination | $( | $( | $( | ||
December 31, | |||
2025 | 2024 | ||
Gross accounts receivable | $ | $ | |
Less: Allowances | ( | ( | |
Accounts receivable | $ | $ | |
Years ended December 31, | |||||
2025 | 2024 | 2023 | |||
Balance at January 1 | $ | $ | $ | ||
Charges to net sales and selling, general and administrative expenses | |||||
Deductions | ( | ( | ( | ||
Write offs | ( | ( | ( | ||
Balance at December 31 | $ | $ | $ | ||
December 31, | |||
2025 | 2024 | ||
Finished goods | $ | $ | |
Work-in-progress | |||
Raw materials | |||
Consumables and spare parts | |||
Inventories | $ | $ | |
December 31, | |||
2025 | 2024 | ||
Land and buildings | $ | $ | |
Plant and equipment | |||
Construction-in-progress | |||
Finance lease right-of-use assets | |||
Property, plant and equipment at cost, excluding forestlands | |||
Less: Accumulated depreciation and impairment | ( | ( | |
Property, plant and equipment, net, excluding forestlands | |||
Forestlands, net of depletion | |||
Property, plant and equipment, net | $ | $ | |
North America | Europe, MEA and APAC | LATAM | Total | ||||
Balance as of December 31, 2023 | $ | $ | $ | $ | |||
Acquisitions and acquisitions adjustments | |||||||
Translation adjustment | ( | ( | ( | ( | |||
Balance as of December 31, 2024 | |||||||
Acquisitions and acquisitions adjustments | ( | ( | |||||
Translation adjustment | |||||||
Balance as of December 31, 2025 | $ | $ | $ | $ |
December 31, | |||||||
2025 | 2024 | ||||||
Gross Carrying Amount | Accumulated Amortization | Gross Carrying Amount | Accumulated Amortization | ||||
Customer relationships | $ | $( | $ | $( | |||
Trade names and trademarks | ( | ( | |||||
Developed technology | ( | ( | |||||
Software assets | ( | ( | |||||
Land use rights | |||||||
Total | $ | $( | $ | $( | |||
Year ended December 31, | Total | |
2026 | $ | |
2027 | ||
2028 | ||
2029 | ||
2030 |
Years ended December 31, | |||||
2025 | 2024 | 2023 | |||
Interest expense | $( | $( | $( | ||
Interest income | |||||
Interest expense, net | $( | $( | $( | ||
Years ended December 31, | |||||
2025 | 2024 | 2023 | |||
Operating lease costs | $( | $( | $( | ||
Variable and short-term lease costs | ( | ( | ( | ||
Finance lease cost: | |||||
Amortization of lease assets | ( | ( | ( | ||
Interest on lease liabilities | ( | ( | ( | ||
Total lease costs | $( | $( | $( | ||
Balance Sheet Location | December 31, | ||||
2025 | 2024 | ||||
Operating leases: | |||||
Operating lease right-of-use assets | Other non-current assets | $ | $ | ||
Current operating lease liabilities | Other current liabilities | $ | $ | ||
Non-current operating lease liabilities | Other non-current liabilities | ||||
Total operating lease liabilities | $ | $ | |||
Finance leases: | |||||
Property, plant and equipment | Property, plant and equipment, net | $ | $ | ||
Accumulated amortization | ( | ( | |||
Property, plant and equipment, net | $ | $ | |||
Current finance lease liabilities | Current portion of debt | $ | $ | ||
Non-current finance lease liabilities | Non-current debt due after one year | ||||
Total finance lease liabilities | $ | $ | |||
December 31, | |||
2025 | 2024 | ||
Weighted average remaining lease term: | |||
Operating leases | |||
Finance leases | |||
Weighted average discount rate: | |||
Operating leases | |||
Finance leases | |||
Years ended December 31, | |||||
2025 | 2024 | 2023 | |||
Cash paid for amounts included in the measurement of lease liabilities: | |||||
Operating cash flows related to operating leases | $ | $ | $ | ||
Operating cash flows related to finance leases | |||||
Financing cash flows related to finance leases | |||||
Leased assets obtained in exchange for lease liabilities: | |||||
Operating leases | $ | $ | $ | ||
Finance leases | $ | $ | $ | ||
Year ended December 31, | Operating Leases | Finance Leases | Total | |||
2026 | $ | $ | $ | |||
2027 | ||||||
2028 | ||||||
2029 | ||||||
2030 | ||||||
Thereafter | ||||||
Total lease payments | $ | $ | $ | |||
Less: Interest | ( | ( | ( | |||
Present value of future lease payments | $ | $ | $ |
December 31, | |||||||
2025 | 2024 | ||||||
Book Value | Fair Value | Book Value | Fair Value | ||||
Debt with fixed interest rates | $ | $ | $ | $ | |||
Level 1 | Level 2 | ||||||
December 31, | December 31, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
Assets | |||||||
Other Investments: | |||||||
Listed | $ | $ | $ | $ | |||
Unlisted | |||||||
Derivatives in cash flow hedging relationships | |||||||
Derivatives not designated as hedging instruments | |||||||
Assets measured at fair value | $ | $ | $ | $ | |||
Liabilities | |||||||
Derivatives in cash flow hedging relationships | $ | $ | $ | $ | |||
Derivatives not designated as hedging instruments | |||||||
Liabilities measured at fair value | $ | $ | $ | $ | |||
Years ended December 31, | |||
2025 | 2024 | ||
Receivable from financial institutions at January 1 | $ | $ | |
Receivables sold to the financial institutions and derecognized | ( | ( | |
Receivables collected by financial institutions | |||
Cash (payments) proceeds (to) from financial institutions | ( | ||
Receivable from financial institutions at December 31 | $ | $ | |
December 31, | |||||||
2025 | 2024 | ||||||
Amount | Weighted average interest rate | Amount | Weighted average interest rate | ||||
$ | $ | $ | |||||
$ | |||||||
$ | |||||||
€ | |||||||
$ | |||||||
$ | |||||||
$ | |||||||
€ | |||||||
€ | |||||||
€ | |||||||
$ | |||||||
$ | |||||||
$ | |||||||
€ | |||||||
$ | |||||||
$ | |||||||
€ | |||||||
$ | |||||||
€ | |||||||
$ | |||||||
$ | |||||||
$ | |||||||
€ | |||||||
$ | |||||||
$ | |||||||
$ | |||||||
Commercial paper | |||||||
Vendor financing and commercial card programs | |||||||
Farm credit facility | |||||||
Other bank loans | |||||||
Finance lease obligations | |||||||
Total debt, excluding fair value adjustments, bond discounts and debt issuance costs | |||||||
Unamortized fair value adjustments, bond discounts and debt issuance costs | ( | ( | |||||
Total debt | |||||||
Less: Current portion of debt | ( | ( | |||||
Non-current debt due after one year | $ | $ | |||||
Year ended December 31, | Total | |
2026 | $ | |
2027 | ||
2028 | ||
2029 | ||
2030 | ||
2031 and thereafter | ||
Unamortized fair value adjustments, bond discounts and debt issuance costs | ( | |
Total | $ |
2025 | 2024 | ||
Within one year | $ | $ | |
Between one and two years | |||
More than two years |
Years ended December 31, | |||||
2025 | 2024 | 2023 | |||
Deferred Bonus Plan | $ | $ | $ | ||
Performance Share Plan | |||||
Performance Share Units | |||||
Restricted Stock Units | |||||
Total share-based compensation expense | $ | $ | $ | ||
Income tax benefit related to share-based compensation expense | $ | $ | $ | ||
Number of shares | Weighted average grant date fair value | ||
Outstanding at January 1 | $ | ||
Granted | |||
Forfeited | ( | ||
Vested | ( | ||
Outstanding at December 31 | $ |
2025 | 2024 | ||
Risk-free interest rate | |||
Expected volatility | |||
Expected term (years) |
Number of shares | Weighted average grant date fair value | ||
Outstanding at January 1 | $ | ||
Granted | |||
Forfeited | ( | ||
Vested | ( | ||
Outstanding at December 31 | $ |
Years ended December 31, | |||||
2025 | 2024 | 2023 | |||
Income before income taxes: | |||||
Domestic (Ireland) | $ | $ | $ | ||
Foreign (U.S.) | ( | ( | ( | ||
Foreign (Other) | |||||
Total income before income taxes | $ | $ | $ | ||
Income tax expense consists of the following components: | |||||
Current tax expense (net of investment tax credits of $ | |||||
Domestic (Ireland) | $ | $ | $ | ||
Foreign (U.S., Federal & State) | |||||
Foreign (Other) | |||||
Total current tax expense | $ | $ | $ | ||
Deferred tax expense (benefit): | |||||
Domestic (Ireland) | $( | $ | $ | ||
Foreign (U.S., Federal & State) | ( | ( | |||
Foreign (Other) | ( | ( | ( | ||
Total deferred tax benefit | ( | ( | ( | ||
Total income tax expense | $ | $ | $ | ||
Total income tax expense consists of the following components: | |||||
Domestic (Ireland) | $ | $ | $ | ||
Foreign (U.S., Federal & State) | ( | ( | |||
Foreign (Other) | |||||